Form 4: Verisk CFO Sells Shares Under Pre-Arranged 10b5-1 Plan

Sentiment:

Insider Transaction Report


Verisk Analytics' Chief Financial Officer, Elizabeth Mann, sold 300 shares of common stock for $242.23 per share on October 15, 2025, as part of a pre-established 10b5-1 trading plan.

Summary

  • Elizabeth Mann, Chief Financial Officer of Verisk Analytics, Inc. (VRSK), reported a sale of common stock.
  • The transaction involved the disposition of 300 shares of Verisk Analytics common stock.
  • The shares were sold at a price of $242.23 per share.
  • The transaction occurred on October 15, 2025.
  • Following this transaction, Ms. Mann beneficially owns 14,865 shares of common stock directly.
  • The sale was executed pursuant to a Rule 10b5-1 trading plan, which Ms. Mann entered into on December 13, 2024.

Sentiment

Score: 5

Explanation: The transaction is a routine insider sale conducted under a pre-arranged 10b5-1 plan, which is a common practice for executives to manage their equity holdings. The small volume of shares sold (300 shares) does not suggest a significant change in management's outlook or company fundamentals.

Positives

  • The sale was conducted under a Rule 10b5-1 plan, indicating a pre-scheduled transaction rather than a reactive sale, which can enhance transparency and mitigate concerns about opportunistic insider trading.

Negatives

  • Insider selling, even if pre-planned, can sometimes be perceived by the market as a lack of confidence, though the small volume in this instance limits its significance.

Risks

  • No specific risks are detailed in this Form 4 filing beyond the general market perception of insider sales.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

  • The shares were sold pursuant to a 10b5-1 plan that Ms. Mann entered into on December 13, 2024.

Industry Context

This insider transaction is a routine disclosure and does not provide specific insights into broader industry trends or competitive landscape for Verisk Analytics. Such filings are common across all industries for executives managing their personal equity holdings.

Comparison to Industry Standards

  • This Form 4 filing is a standard regulatory disclosure for insider transactions and does not contain information that allows for a direct comparison of company performance or project results against global benchmarks or specific comparable companies.

Stakeholder Impact

  • Shareholders: A minor, pre-planned sale by a CFO is unlikely to have a material impact on shareholder sentiment or the company's stock price, given the small volume relative to the company's market capitalization.

Next Steps

  • The filing does not specify any future actions, events, or milestones for the company or the reporting person beyond the reported transaction.

Key Dates

DateDescription
12/13/2024Date Elizabeth Mann entered into the Rule 10b5-1 trading plan.
10/15/2025Date of the reported transaction (sale of common stock).

Recommendation

hold

The sale of 300 shares by the CFO, Elizabeth Mann, is a small, pre-planned transaction executed under a 10b5-1 plan. This type of routine insider activity is generally not indicative of a change in the company's fundamental prospects or management's long-term confidence. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Verisk Analytics, VRSK, Elizabeth Mann, Chief Financial Officer, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Equity Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.